0.00Open0.00Pre Close0 Volume0 Open Interest4.00Strike Price0.00Turnover0.00%IV177.78%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier20DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.88Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Vivani Medical Stock Discussion
Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia
NPM-115 clinical program utilizes a miniature, GLP-1 (exenatide) implant designed to provide comparable efficacy to semaglutide, the active ingredient in Ozempic®/Wegovy®, with twice-yearly administration
Study will represent the first clinical application of NanoPortal™, the Company's proprietary drug implant pla...
EXCLUSIVE: Vivani Medical Tells Benzinga 'Felines Share Many Pathophysiologic Obesity Phenotypes With Humans, Further Supporting Clinical Evaluations of Miniature, Subdermal GLP-1 Implants for Obesity Reduction'
$Vivani Medical (VANI.US)$
📊⚡️📊
No comment yet